Long Term Follow up of the LTOG Cohort (NCT04787822) | Clinical Trial Compass
By InvitationNot Applicable
Long Term Follow up of the LTOG Cohort
United States4,000 participantsStarted 2021-06-15
Plain-language summary
The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.
Who can participate
Age range
13 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
Long-term phenotyping of CLAD
* Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers
Long-term functional status and well-being
* Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers
* Alive
Exclusion Criteria
Long-term phenotyping of CLAD
* Lung transplant recipient not enrolled in LTOG cohort research studies
Long-term functional status and well-being
* Lung transplant recipient not enrolled in the LTOG cohort research studies
* Lung transplant recipient not receiving post-transplant follow-up care at a participating LTOG center
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Timeframe: From date of transplant to the development of CLAD, up to 25 years
2
Functional status phenotyping
Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years
3
Well being phenotyping-LT-VLA
Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years
4
Well being phenotyping-LT-QOL
Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years